Result of GM and Subscription

Summary by AI BETAClose X

Malvern International PLC announced that all resolutions were passed at its General Meeting, allowing the company to proceed with the issuance of new ordinary shares. Directors and senior management have subscribed for £263,500 worth of new ordinary shares at 23 pence each, totaling 1,145,649 shares. This subscription, along with shares from a conditional placing and retail offer, will result in the admission of 4,140,812 new ordinary shares to AIM, expected on or around March 6, 2026. Following this, the total number of ordinary shares in issue will be 33,471,712.

Disclaimer*

Malvern International PLC
05 March 2026
 

 

 

 

5 March 2026

 

Malvern International PLC

("Malvern" or the "Company")

 

Result of General Meeting

and Directors' Subscription

 

Malvern International plc (AIM: MLVN), a global partner in learning and skills development, is pleased to announce that, at its General Meeting held earlier today, all resolutions were duly passed. The results of the voting will be included on the Company's website in due course, www.malverninternational.com.

Further to the announcement at 7 a.m. on 17 February 2026 and following the announcement of the Company's final results for the nine months ended 30 September 2025, Directors and senior management have subscribed for, in aggregate, £263,500 through the issue of 1,145,649 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") at the issue price of 23 pence ("Directors' Subscription Shares").

Following the passing of Resolution 1, the Company will proceed with the allotment and issue of the 2,415,172 new Ordinary Shares pursuant to the conditional placing announced on 17 February 2026, the 579,991 new Ordinary Shares pursuant to the retail offer announced on 24 February 2026, and the Directors' Subscription Shares, as described in the Company's circular published on 17 February 2026.

Application has been made to the London Stock Exchange for admission of 4,140,812 new Ordinary Shares to trading on AIM (the "Admission"). It is expected that Admission will become effective and dealings will commence at 8.00 a.m. on or around 6 March 2026. The new Ordinary Shares will be issued fully paid and will rank pari passu in all respects with the Company's Existing Ordinary Shares.

Following Admission, the total number of Ordinary Shares in the capital of the Company in issue will be 33,471,712 Ordinary Shares with voting rights. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's share capital under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

Malvern International Plc

Richard Mace - Chief Executive Officer

www.malverninternational.com

Via Zeus



Zeus - Nominated Adviser and Broker

Mike Coe / James Bavister

https://zeuscapital.co.uk/

0203 829 5000

 

 

Notes to Editors:

Malvern International is a learning and language skills development partner, offering international students essential academic and English language skills, cultural experiences and the support they need to thrive in their academic studies, daily life and career development.

University Pathways provides on- and off-campus in-sessional and pre-sessional programmes to support international students in progressing to a wide range of universities and undergraduate courses. Malvern assists its university partners with international student recruitment and conversion, admissions, fee collection, and course delivery, including teaching, orientation, and student support.

English Language Teaching is provided to young learners through fully immersive residential English language centres and customised language programmes at high-quality locations.

For further investor information go to www.malverninternational.com.

 

1.  

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

i)          Richard Mace

ii)         Alan Caroll

iii)        Mark Elliott

iv)        Marzena Mace

v)         Katherine Mace

vi)        Alexander Mace

vii)       Stephen Harvey

 

2.

Reason for the notification

a.

Position/status

i)          Director

ii)         Director

iii)        Director

iv)        Wife of Richard Mace

v)         Daughter of Richard Mace

vi)        Son of Richard Mace

vii)       PDMR

b.

Initial notification /Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Malvern International plc

b.

LEI

213800VWAV2HXY1OUT29

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 1 pence

 

 

GB00BNBVJZ07

b.

Nature of the transaction

Subscription of Ordinary Shares

c.

Price(s) and volume(s)


Price

Ordinary Shares

i

23p

307,393

ii

23p

200,000

iii

23p

60,869

iv

23p

132,608

v

23p

40,869

vi

23p

40,869

vii

23p

43,478

d.

Aggregated information

Aggregated volume

Price

 

826,086

23p

e.

Date of the transaction

5 March 2026

f.

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100